Evidence map›Paper›PMID 32460629›Full record

ArticleMetabolic syndrome and related disorders2020

The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.

Xiuying Zhang, Xianghai Zhou, Xueyao Han, Zuodi Fu, Lianying Wang, Yufeng Li, Linong Ji

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolic syndrome and related disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xiuying ZhangDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, Beijing, China.
Xianghai ZhouDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, Beijing, China.
Xueyao HanDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, Beijing, China.
Zuodi FuDepartment of Endocrinology and Metabolism, Pinggu Hospital, Capital Medical University, Beijing, China.
Lianying WangDepartment of Endocrinology and Metabolism, Pinggu Hospital, Capital Medical University, Beijing, China.
Yufeng LiDepartment of Endocrinology and Metabolism, Pinggu Hospital, Capital Medical University, Beijing, China.
Linong JiDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Centre, Beijing, China.
Beijing Anding Hospital · CNPeking University · CNPeking University People's Hospital · CNCapital Medical University · CN

Funding

Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
FIC NIH HHS R25 TW009345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBeijingBiomarkersBlood GlucoseComorbidityFemaleGlucose IntoleranceGlucose Tolerance TestHumansMaleMiddle AgedNon-alcoholic Fatty Liver DiseasePrevalenceRisk AssessmentRisk FactorsBiomarkersBlood Glucoseepidemiologyglucose intolerancenonalcoholic fatty liver diseaseobesitytype 2 diabetes

Identifiers

PMID32460629
PMCPMC7407000
OpenAlexW3028631884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.